2016
DOI: 10.1039/c5ra21068b
|View full text |Cite
|
Sign up to set email alerts
|

The effect of protein concentration on the viscosity of a recombinant albumin solution formulation

Abstract: ReuseUnless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy solely for the purpose of non-commercial research or private study within the limits of fair dealing. The publisher or other rights-holder may allow further reproduction and re-use of this version -refer to the White Rose Research Online record for this item. Where records identify the publish… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
40
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(44 citation statements)
references
References 47 publications
4
40
0
Order By: Relevance
“…As a cell grows, mass is accumulated and there is an increase in the physical size, with the largest contribution to cellular dry mass being typically from proteins 40 . It is likely that the viscous component of cell behavior is influenced by the increase in proteins in the cytoplasm 41 , 42 . We observe a consistent and steady increase in our measurements at mitosis against interphase ( p ≈ 0.001) as shown in Fig.…”
Section: Discussionmentioning
confidence: 99%
“…As a cell grows, mass is accumulated and there is an increase in the physical size, with the largest contribution to cellular dry mass being typically from proteins 40 . It is likely that the viscous component of cell behavior is influenced by the increase in proteins in the cytoplasm 41 , 42 . We observe a consistent and steady increase in our measurements at mitosis against interphase ( p ≈ 0.001) as shown in Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Typical therapeutic mAbs formulations have concentrations around 100 mg/mL [2, 3], higher concentrations may yield prohibitively high viscosities. It is clear that the high viscosities of antibody solutions mostly arise from protein–protein interactions [414]. But, it is not yet clear how to rationally design formulations that can both maximize efficacy (protein concentration) and minimize viscosity [15, 16].…”
Section: Introductionmentioning
confidence: 99%
“…As the particle size becomes finer, the viscosity becomes lower. However, the apparent viscosity starts to increase again at 2% w/w, which might be due to the increment of the protein–protein aggregations of the unabsorbed protein in a continuous phase of the high SC concentration (Gonçalves et al, ).…”
Section: Resultsmentioning
confidence: 99%